Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             136 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure Stenger, Elizabeth O.

10 p. 2196-2205
artikel
2 Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency Gidley, Gillian N.

10 p. 1076-1088
artikel
3 Actin/microtubule crosstalk during platelet biogenesis in mice is critically regulated by Twinfilin1 and Cofilin1 Becker, Isabelle C.

10 p. 2124-2134
artikel
4 Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis Djulbegovic, Mia

10 p. 2132-2142
artikel
5 Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant Sharma, Prashant

10 p. 2227-2235
artikel
6 A functional DC cross talk promotes human ILC homeostasis in humanized mice Lopez-Lastra, Silvia

10 p. 601-614
artikel
7 A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome Güney, Ekin

10 p. 3189-3193
artikel
8 Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination Lee, Hye Kyung

10 p. 2214-2227
artikel
9 Analysis of the thrombotic and fibrinolytic activities of tumor cell–derived extracellular vesicles Durrieu, Ludovic

10 p. 1054-1065
artikel
10 Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax Candoni, Anna

10 p. 3068-3071
artikel
11 Anti-HK antibody reveals critical roles of a 20-residue HK region for Aβ-induced plasma contact system activation Chen, Zu-Lin

10 p. 3090-3101
artikel
12 A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL Jain, Nitin

10 p. 1958-1966
artikel
13 Applying CRISPR-Cas9 screens to dissect hematological malignancies Iyer, Deepak Narayanan

10 p. 2252-2270
artikel
14 A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL Mato, Anthony R.

10 p. 1568-1573
artikel
15 Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia Kurtz, Stephen E.

10 p. 3062-3067
artikel
16 A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation Paquette, Miney

10 p. 1638-1646
artikel
17 Bilateral retinal detachment after chimeric antigen receptor T-cell therapy Denton, Christopher C.

10 p. 2158-2162
artikel
18 Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation Janardan, Sanyukta

10 p. 3058-3061
artikel
19 Caplacizumab as frontline therapy in addition to standard treatment in iTTP Cid, Joan

10 p. 2129-2131
artikel
20 CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up Parker, Helen

10 p. 1116-1119
artikel
21 Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy Reimann, Hannah

10 p. 2066-2069
artikel
22 Ceriani L, Gritti G, Cascione L, et al. SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Adv. 2020;4(6):1082-1092.
10 p. 2135
artikel
23 Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD Pemmaraju, Naveen

10 p. 3027-3035
artikel
24 Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report Kudo, Ko

10 p. 3162-3166
artikel
25 Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents Giri, Smith

10 p. 2245-2253
artikel
26 Circulating primitive murine erythroblasts undergo complex proteomic and metabolomic changes during terminal maturation Nemkov, Travis

10 p. 3072-3089
artikel
27 Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial Johnson, Peter W. M.

10 p. 2008-2017
artikel
28 Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML Tsai, Cheng-Hong

10 p. 2456-2466
artikel
29 Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States Zeidan, Amer M.

10 p. 2192-2201
artikel
30 Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms Lewis, Natasha E.

10 p. 2261-2271
artikel
31 Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study Fein, Joshua A.

10 p. 2143-2152
artikel
32 Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy Li, Shuang

10 p. 2202-2212
artikel
33 Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression Sharma, Neekun

10 p. 1563-1567
artikel
34 Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia Tuleja, Aleksandra

10 p. 3114-3125
artikel
35 Direct evidence for a polygenic etiology in familial multiple myeloma Halvarsson, Britt-Marie

10 p. 619-623
artikel
36 Doguer C, Ha J-H, Gulec S, Vulpe CD, Anderson GJ, Collins JF. Intestinal hephaestin potentiates iron absorption in weanling, adult, and pregnant mice under physiological conditions. Blood Adv. 2017;1(17):1335-1346.
10 p. 1115
artikel
37 Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial Zwicker, Jeffrey I.

10 p. 2254-2260
artikel
38 Editorial Board
10 p. i
artikel
39 Editorial Board
10 p. i
artikel
40 Editorial Board
10 p. i
artikel
41 Editorial Board
10 p. i
artikel
42 Editorial Board
10 p. i
artikel
43 Editorial Board
10 p. i
artikel
44 Editorial Board
10 p. i
artikel
45 Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features Zhang, Xian

10 p. 2325-2338
artikel
46 Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease Shrestha, Pradeep

10 p. 2181-2195
artikel
47 Epidemiology of AL amyloidosis: a real-world study using US claims data Quock, Tiffany P.

10 p. 1046-1053
artikel
48 Four AAs increase DMT1 abundance in duodenal brush-border membrane vesicles and enhance iron absorption in iron-deprived mice Woloshun, Regina R.

10 p. 3011-3021
artikel
49 Front Matter
10 p. ii
artikel
50 Gata2-regulated Gfi1b expression controls endothelial programming during endothelial-to-hematopoietic transition Koyunlar, Cansu

10 p. 2082-2093
artikel
51 G6b-B regulates an essential step in megakaryocyte maturation Becker, Isabelle C.

10 p. 3155-3161
artikel
52 Gender equity analysis of nontrainee hemostasis and thrombosis recognition award recipients Jacobs, Jeremy W.

10 p. 1991-1995
artikel
53 Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib Kok, Chung H.

10 p. 1610-1621
artikel
54 Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia McMahon, Christine M.

10 p. 1581-1585
artikel
55 Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin Reeves, Sarah L.

10 p. 1574-1580
artikel
56 High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma Senjo, Hajime

10 p. 2286-2296
artikel
57 High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry Sayar, Zara

10 p. 2139-2142
artikel
58 Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia Escherich, Carolin

10 p. 2177-2180
artikel
59 IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells Camelo, Ana

10 p. 577-589
artikel
60 Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma Niazi, Shehzad

10 p. 1120-1128
artikel
61 Inaccuracies in assignment of patient race and ethnicity: implications for unrelated donor searches and health care delivery Fingrut, Warren B.

10 p. 1996-1999
artikel
62 Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant Pérez-Valencia, Amanda Isabel

10 p. 2018-2031
artikel
63 Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase Fordham, Sarah E.

10 p. 1157-1169
artikel
64 INR and vitamin K–dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma Hood, Christopher

10 p. 2206-2213
artikel
65 Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia Silveira, Douglas R.A.

10 p. 2339-2350
artikel
66 Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome Shah, Nirav N.

10 p. 2119-2122
artikel
67 JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL Yumeen, Sara

10 p. 2213-2226
artikel
68 Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation Lorentino, Francesca

10 p. 3053-3057
artikel
69 Lineage switching of the cellular distribution of BRAF V600E in multisystem Langerhans cell histiocytosis Milne, Paul

10 p. 2171-2176
artikel
70 Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries Valvert, Fabiola

10 p. 2447-2455
artikel
71 Lupus anticoagulant test persistence over time and its associations with future thrombotic events Colling, Meaghan E.

10 p. 2957-2966
artikel
72 Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes Remer, Hallie B.

10 p. 2977-2980
artikel
73 Mechano-covalent protection of coagulation factor VIII by von Willebrand factor Butera, Diego

10 p. 2117-2128
artikel
74 Membrane bending and sphingomyelinase-associated, sulfatide-dependent hypoxic adhesion of sickle mature erythrocytes Goreke, Utku

10 p. 2094-2104
artikel
75 Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness Pirillo, Chiara

10 p. 3126-3141
artikel
76 Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma Mellors, Patrick W.

10 p. 2236-2244
artikel
77 Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences Wiercioch, Wojtek

10 p. 2351-2365
artikel
78 MicroRNA-31 regulates T-cell metabolism via HIF1α and promotes chronic GVHD pathogenesis in mice Wu, Yongxia

10 p. 3036-3052
artikel
79 Miles J, Bailey SL, Obenaus AM, et al. Storage temperature determines platelet GPVI levels and function in mice and humans. Blood Adv. 2021;5(19):3839-3849.
10 p. 3102-3105
artikel
80 Missense VKOR mutants exhibit severe warfarin resistance but lack VKCFD via shifting to an aberrantly reduced state Li, Shuang

10 p. 2271-2282
artikel
81 Mitochondrial localization and moderated activity are key to murine erythroid enucleation Liang, Raymond

10 p. 2490-2504
artikel
82 Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients Yoshioka, Hideki

10 p. 1066-1075
artikel
83 Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains Shamanaev, Aleksandr

10 p. 3142-3154
artikel
84 Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA Garcia-Gisbert, Nieves

10 p. 3178-3188
artikel
85 Myb drives B-cell neoplasms and myeloid malignancies in vivo Pieters, Tim

10 p. 2987-2991
artikel
86 Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules Barberi, Chiara

10 p. 2297-2307
artikel
87 Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment Schoeberl, Florian

10 p. 3022-3026
artikel
88 Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study Handa, Shivani

10 p. 1967-1975
artikel
89 Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease Zeno, Rachel N.

10 p. 2245-2251
artikel
90 Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease Kinoshita, Hannah

10 p. 2105-2116
artikel
91 Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe Rafii, Hanadi

10 p. 1976-1986
artikel
92 Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs Asimomitis, Georgios

10 p. 2992-3005
artikel
93 Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas Forconi, Catherine S.

10 p. 1101-1114
artikel
94 Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia Comont, Thibault

10 p. 2136-2138
artikel
95 Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation Fine, Noah

10 p. 1622-1637
artikel
96 Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods Kotrová, Michaela

10 p. 3006-3010
artikel
97 Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma Alonso, Rafael

10 p. 2163-2171
artikel
98 Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy Meloni, Antonella

10 p. 2237-2240
artikel
99 Quinoline-3-carboxamides such as tasquinimod are not specific inhibitors of S100A9 Pelletier, Martin

10 p. 1170-1171
artikel
100 Racial disparities in cancer-associated thrombosis Datta, Tatini

10 p. 3167-3177
artikel
101 Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab Badar, Talha

10 p. 2308-2316
artikel
102 Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease DePriest, Brittany Paige

10 p. 2981-2986
artikel
103 Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy Alquezar-Artieda, Natividad

10 p. 2228-2236
artikel
104 Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma Saito, Masato

10 p. 2180-2191
artikel
105 Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells Abreu, Rodrigo

10 p. 1089-1100
artikel
106 Search for multiple myeloma risk factors using Mendelian randomization Went, Molly

10 p. 2172-2179
artikel
107 Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) Han, Se young

10 p. 2481-2489
artikel
108 Shamay M, Kanakry JA, Low JSW, et al. CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma. Blood Adv. 2020;4(8):1624-1627.
10 p. 2123
artikel
109 Small but mighty: T-replete cords for myeloid disease LaBelle, James L.

10 p. 2153-2154
artikel
110 SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms Saha, Subha

10 p. 3106-3113
artikel
111 Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors Mensah, Afua Adjeiwaa

10 p. 2467-2480
artikel
112 Survival outcomes in the very elderly with DLBCL prior to and after the introduction of rituximab: a US population-based study Giri, Upama

10 p. 615-618
artikel
113 Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease Gelbenegger, Georg

10 p. 1987-1990
artikel
114 Systematic review of outcome reporting in studies of SCD and pregnancy: marked heterogeneity hinders meaningful data synthesis Ashwal, Eran

10 p. 2004-2007
artikel
115 Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses Manna, Alak

10 p. 2143-2157
artikel
116 T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy Horgan, Claire

10 p. 2155-2165
artikel
117 TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm Beird, Hannah

10 p. 2000-2003
artikel
118 The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis Qiu, Jiajing

10 p. 1130-1145
artikel
119 The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia Branch, Donald R.

10 p. 2166-2170
artikel
120 The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells Lan, Xianjiang

10 p. 1586-1597
artikel
121 Therapy selection for Hodgkin lymphoma in sickle cell disease: balancing risks and benefits Fraley, Claire E.

10 p. 2042-2046
artikel
122 The transcriptional landscape of human liver endothelial cells Toledano-Sanz, Pablo

10 p. 2047-2052
artikel
123 Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders Harrington, Patrick

10 p. 1954-1957
artikel
124 Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice Grover, Steven P.

10 p. 1945-1953
artikel
125 Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study Skajaa, Nils

10 p. 2070-2081
artikel
126 Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 Page, Evaren E.

10 p. 590-600
artikel
127 TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia Sakoda, Teppei

10 p. 2053-2065
artikel
128 Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality Ustun, Celalettin

10 p. 2317-2324
artikel
129 Tkaczynski E, Arulselvan A, Tkaczynski J, et al. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia. Blood Adv. 2018;2(7):754-761.
10 p. 1129
artikel
130 TLR-activated repression of Fe-S cluster biogenesis drives a metabolic shift and alters histone and tubulin acetylation Tong, Wing-Hang

10 p. 1146-1156
artikel
131 Tranexamic acid modulates the immune response and reduces postsurgical infection rates Draxler, Dominik F.

10 p. 1598-1609
artikel
132 Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy Annunzio, Kaitlin

10 p. 2241-2244
artikel
133 Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice Shi, Qizhen

10 p. 2272-2285
artikel
134 Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy Overvad, Thure Filskov

10 p. 2967-2976
artikel
135 What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients Barata, Anna

10 p. 2032-2041
artikel
136 Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients Machado, Clarisse Martins

10 p. 624-627
artikel
                             136 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland